Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
NPJ Parkinson'S Disease
|
July 15, 2025
Classification of Parkinson's disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome
Caitlin Walton-Doyle, Beatrice Heim, Eleanor Sinclair, et al.
The Journal of Nutrition, Health & Aging
|
February 8, 2026
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach
Gerald Klinglmair, Maximilian Lutz, Tatia Telia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2025
Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view
Karolina Poplawska-Domaszewicz, Valtteri Kaasinen, Anton Adriaan van der Plas, et al.
Annals of Neurology
|
August 7, 2020
Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Marina Peball, Florian Krismer, Hans-Günther Knaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2018
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B Postuma, Werner Poewe, Irene Litvan, et al.
Annals of Clinical and Translational Neurology
|
July 20, 2024
Objective and subjective cognitive outcomes one year after COVID-19
Laura Zamarian, Verena Rass, Elisabeth Goettfried, et al.
Gerontology
|
September 11, 2018
Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study
Marina Peball, Philipp Mahlknecht, Mario Werkmann, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 28, 2021
Factors associated with impaired quality of life three months after being diagnosed with COVID-19
Verena Rass, Bogdan-Andrei Ianosi, Laura Zamarian, et al.
Annals of Clinical and Translational Neurology
|
October 20, 2022
Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking
Federico Carbone, Laura Zamarian, Verena Rass, et al.
European Journal of Neurology
|
March 8, 2021
Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study
Verena Rass, Ronny Beer, Alois Josef Schiefecker, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
NPJ Parkinson'S Disease
|
July 15, 2025
Classification of Parkinson's disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome
Caitlin Walton-Doyle, Beatrice Heim, Eleanor Sinclair, et al.
The Journal of Nutrition, Health & Aging
|
February 8, 2026
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a nonlinear modeling approach
Gerald Klinglmair, Maximilian Lutz, Tatia Telia, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2025
Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view
Karolina Poplawska-Domaszewicz, Valtteri Kaasinen, Anton Adriaan van der Plas, et al.
Annals of Neurology
|
August 7, 2020
Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Marina Peball, Florian Krismer, Hans-Günther Knaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2018
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Ronald B Postuma, Werner Poewe, Irene Litvan, et al.
Annals of Clinical and Translational Neurology
|
July 20, 2024
Objective and subjective cognitive outcomes one year after COVID-19
Laura Zamarian, Verena Rass, Elisabeth Goettfried, et al.
Gerontology
|
September 11, 2018
Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study
Marina Peball, Philipp Mahlknecht, Mario Werkmann, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 28, 2021
Factors associated with impaired quality of life three months after being diagnosed with COVID-19
Verena Rass, Bogdan-Andrei Ianosi, Laura Zamarian, et al.
Annals of Clinical and Translational Neurology
|
October 20, 2022
Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking
Federico Carbone, Laura Zamarian, Verena Rass, et al.
European Journal of Neurology
|
March 8, 2021
Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study
Verena Rass, Ronny Beer, Alois Josef Schiefecker, et al.
Page
of 8